ETNB - 89bio Inc
14.84
0 0%
Share volume: 55,645,393
Last Updated: 10-29-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$14.84
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-09-2024 | 08-05-2024 | 11-07-2024 | 02-27-2025 | 05-02-2025 | |
| Assets | ||||||
| Total Assets | 577.322 M | 582.138 M | 458.297 M | 478.685 M | 685.031 M | |
| Current Assets | 574.782 M | 579.854 M | 456.206 M | 476.450 M | 682.944 M | |
| Inventories | 2.118 M | 1.942 M | 1.760 M | 1.572 M | 1.409 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 344.715 M | 319.166 M | 332.363 M | 313.895 M | 323.384 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 217.573 M | 212.218 M | 91.411 M | 126.060 M | 315.396 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 37.000 K | 27.000 K | 17.000 K | 23.000 K | 85.000 K | |
| Other Assets | 385.000 K | 315.000 K | 314.000 K | 640.000 K | 593.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 577.322 M | 582.138 M | 458.297 M | 478.685 M | 685.031 M | |
| Total liabilities | 66.783 M | 67.221 M | 80.195 M | 77.896 M | 79.573 M | |
| Total current liabilities | 38.241 M | 41.653 M | 39.131 M | 36.129 M | 37.884 M | |
| Accounts Payable | 15.352 M | 17.461 M | 19.490 M | 15.382 M | 14.790 M | |
| Other liabilities | 5.477 M | 5.213 M | 5.520 M | 6.035 M | 5.749 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 23.065 M | 20.355 M | 35.544 M | 35.732 M | 35.940 M | |
| Other liabilities | 5.477 M | 5.213 M | 5.520 M | 6.035 M | 5.749 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 510.539 M | 514.917 M | 378.102 M | 400.789 M | 605.458 M | |
| Common stock | 1.020 B | 1.073 B | 1.083 B | 1.225 B | 1.501 B | |
| Retained earnings | -509.113 M | -557.084 M | -706.157 M | -824.511 M | -895.786 M |